The Year in Lipid Disorders Volume 2

Description

Lipid disorders are among the primary risk factors in developing atherosclerosis and heart disease. Providing an up-to-date insight into the latest research into lipid disorders, and the implications of this research for daily clinical practice, this collection includes an overview of the latest developments in this complex field by reviewing the most significant papers published in the medical journals on lipid disorders over the last eighteen months.

Benefits:
* Literature update on a key risk factor in cardiovascular disease * Enables the doctor to survey the latest literature with the assistance of expert reviewers

Edited by:
PP Toth, University of Illinois College of Medicine, Peoria, and Southern Illinois University School of Medicine, Springfield, Illinois, USA.

Readership:
General physicians * Cardiologists * Diabetologists * Nephrologists * Doctors in training

CONTENTS

Part I Clinical aspects in coronary artery disease
1 PCSK9: Molecular functions, polymorphisms, and risk for atherosclerotic disease. M Abifadel
2 Metabolic syndrome, diabetes and cardiovascular risk. CD Byrne
3 Diet and exercise in the prevention and treatment of diabetes and coronary heart disease. G Hu and J Tuomilehto
4 Technologies for assessment of atherosclerotic burden in man. C Berry

Part II Lipids, lipoproteins and atherosclerosis
5 Ezetimibe. H Davis
6 Oxidative stress, lipoprotein oxidation and atherosclerosis. RW James
7 Metabolism of apolipoprotein B-100-containing lipoproteins in dyslipidaemias. GF Watts
8 Triglycerides and atherosclerosis. T Dayspring and GS Pokrywka

Part III Prevention and treatment strategies
9 The JUPITER Trial: the intersection between inflammation, statin therapy, and risk for cardiovascular events. PP Toth and PM Ridker
10 New clinical trials of lipid-regulating agents. AG Olsson
11 Statin myopathy. CR Harper
12 Nuclear receptors (PPARs, LXRs) and their role in regulating lipid metabolism. JS Millar

Part IV Infection, inflammation and secondary causes of atherosclerosis
13 Inflammation, inflammatory disease, and coronary atherosclerosis. RS Rosenson
14 Mechanisms of insulin resistance and impact on atherosclerosis. RP Raghavan
15 Haemostasis–dyslipidaemia interactions in coronary heart disease. VJ Karthikeyan

Abbreviations
General index